Literature DB >> 12955048

Renal artery aneurysms: diagnosis, management and outcomes.

P K Henke1, J C Stanley.   

Abstract

Renal artery aneurysms are an uncommon vascular entity and are more likely to affect younger patients without significant atherosclerotic risk factors as compared to patients with renal artery occlusive disease. Hypertension is a commonly associated disease and the renal artery aneurysm may be causal, exclusive of renal artery occlusive disease. Diagnosis is often made incidentally but arteriography is essential for good operative planning. The main complication of RAA is rupture, which is increased in peripartum females. Operative therapy is primarily in situ aneurysmectomy and angioplastic closure or exclusion and bypass, usually with autologous conduit. It is currently recommended that in good operative risk patients, repair is recommended for RAA >1.0 cm when hypertension present and RAA >1.5 to 2.0 cm when no hypertension present. Given the anatomic complexity of these lesions, little role for endovascular therapy is forecast.

Entities:  

Mesh:

Year:  2003        PMID: 12955048

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  4 in total

1.  Giant renal aneurysm with arteriovenous fistula.

Authors:  Takayoshi Kato; Hisato Takagi; Kenji Ogaki; Shuji Oba; Takuya Umemoto
Journal:  Heart Vessels       Date:  2006-07       Impact factor: 2.037

2.  Embolization of ruptured renal artery aneurysms.

Authors:  Gang Li; Yanqiu Sun; Hualin Song; Yi Wang
Journal:  Clin Exp Nephrol       Date:  2015-01-25       Impact factor: 2.801

3.  Emergent coil embolization for ruptured renal artery aneurysm.

Authors:  Makiyo Hagihara; Akira Kitagawa; Yuichiro Izumi; Yukihiko Ohshima; Eisuke Katsuda; Joe Matsuda; Seiji Kamei; Junko Kimura; Toshiki Kawamura; Tsuneo Ishiguchi
Journal:  Jpn J Radiol       Date:  2009-08-28       Impact factor: 2.374

4.  Wide-neck renal artery aneurysm: parenchymal sparing endovascular treatment with a new device.

Authors:  Michele Rossi; Gianluca Maria Varano; Gianluigi Orgera; Alberto Rebonato; Florindo Laurino; Cosimo De Nunzio
Journal:  BMC Urol       Date:  2014-05-28       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.